Breaking News
13 minutes ago
Vaibhavi M.
Telix Pharmaceuticals Limited NDA for Pixclara (TLX101-Px) accepted by FDA for glioma imaging, with PDUFA date set for September 2026 to support brain cancer diagnosis.
Vaibhavi M.
Glenmark Pharmaceuticals Limited secures FDA approval for progesterone vaginal inserts 100 mg, a generic of Endometrin, to treat infertility-related conditions in women’s health.
Vaibhavi M.
ANI Pharmaceuticals launches generic Isosorbide Mononitrate tablets for angina treatment following FDA approval, expanding access to affordable nitrate therapy options.
Vaibhavi M.
Plus Therapeutics gains FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas and ependymoma, advancing targeted radiotherapy for rare brain tumors.
Vaibhavi M.